Assura Plc (LON:AGR - Get Free Report) insider Jonathan Murphy sold 1,572,585 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of GBX 50 ($0.68), for a total transaction of £786,292.50 ($1,066,303.91).
Jonathan Murphy also recently made the following trade(s):
- On Tuesday, August 12th, Jonathan Murphy sold 1,394,556 shares of Assura stock. The shares were sold at an average price of GBX 50 ($0.68), for a total transaction of £697,278 ($945,589.91).
- On Tuesday, August 5th, Jonathan Murphy bought 663 shares of Assura stock. The stock was purchased at an average price of GBX 49 ($0.66) per share, with a total value of £324.87 ($440.56).
- On Wednesday, July 9th, Jonathan Murphy bought 607 shares of Assura stock. The stock was purchased at an average price of GBX 50 ($0.68) per share, with a total value of £303.50 ($411.58).
Assura Stock Performance
LON:AGR traded up GBX 0.28 ($0.00) during mid-day trading on Monday, hitting GBX 48.04 ($0.65). The stock had a trading volume of 57,705,824 shares, compared to its average volume of 29,146,250. Assura Plc has a twelve month low of GBX 35.24 ($0.48) and a twelve month high of GBX 50.95 ($0.69). The stock has a market cap of £1.56 billion, a price-to-earnings ratio of -45.92, a PEG ratio of 3.60 and a beta of 0.37. The company's 50 day simple moving average is GBX 49.82 and its 200 day simple moving average is GBX 47.18. The company has a debt-to-equity ratio of 85.05, a quick ratio of 2.84 and a current ratio of 0.89.
Assura (LON:AGR - Get Free Report) last issued its earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. On average, equities research analysts forecast that Assura Plc will post 3.5830389 earnings per share for the current year.
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Further Reading

Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.